What are the current driving questions in immune repertoire research?

Competing Interests: Declaration of interests V.G. declares advisory board positions in aiNET GmbH, Enpicom B.V., Specifica Inc., Adaptyv Biosystems, EVQLV, and Omniscope. V.G. is a consultant for Roche/Genentech and immunai. E.T.L.P. has no financial interests to declare; however, she does serve on the board of directors of the Antibody Society (TAbS) and on the executive sub-committee of the Adaptive Immune Receptor Repertoire (AIRR) Community. S.T.R. is a co-founder of deepCDR Biologics (acquired by Alloy Therapeutics) and co-founder of Engimmune Therapeutics. S.T.R. is on the Scientific Advisory Board of Alloy Therapeutics and Engimmune Therapeutics. S.T.R. holds shares in Alloy Therapeutics and Engimmune Therapeutics.